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The Class 3 Semaphorins (Sema3s) are a sub-family of proteins whose known biological
roles are varied and growing. The mechanism of action of the Sema3s requires binding to
transmembrane receptors that comprise heteromeric complexes of Neuropilins, Plexins
and cell adhesion molecules (CAMs). However, knowledge of the receptor components of
the Sema3s remains incomplete, and there may be receptor components which are as yet
undiscovered. The receptor complexes of the Sema3s share receptor components with
each other, and it is the specific combination of these components within a heteromeric
complex that is thought to give rise to selective binding and signalling for individual
Sema3s. This crosstalk makes it experimentally difficult to define a single holoreceptor
for each Sema3. Furthermore, the receptor composition for a given Sema3 may differ
between cell types, and change as a function of developmental state or pathological
situation. Nevertheless, there are at least some known differences in the constitutive
structure of the receptors for the Sema3s. For example in neural cells, Sema3a and
Sema3f signal through different Neuropilins (Nrp1 and Nrp2 respectively) and L1cam only
appears important for Sema3a signaling, while Nrcam forms a complex with Nrp2. Further
complexity arises from crosstalk of other families of ligands (e.g., VEGF ) with Sema3
receptor components. Thus the Sema3s, which have been shown as antagonists for each
other, can also act as antagonists for other families of molecules. This review compiles
experimental evidence describing the receptor components for the Sema3s, detailing
the current state of knowledge of which components are important for signaling of each
Sema3 before going on to consider possible future directions for the field.
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INTRODUCTION
The Class 3 Semaphorins (Sema3s) were first discovered as
axon guidance molecules (Kolodkin et al., 1992; Luo et al.,
1993), and in vertebrates are the only secreted members of
the Semaphorin family (Semaphorin Nomenclature Committee,
1999). The known Sema3s consist of Sema3a through Sema3g
(Kolodkin et al., 1993; Luo et al., 1993, 1995; Püschel et al.,
1995; Roche et al., 1996; Sekido et al., 1996; Xiang et al., 1996;
Feiner et al., 1997; Stevens and Halloran, 2005; Taniguchi et al.,
2005), and their known physiological and pathological functions
have expanded to include axon attraction and repulsion, apop-
tosis, cell migration, growth cone collapse, immune response,
organogenesis, tumour suppression and promotion, and vascu-
lature development (Yazdani and Terman, 2006; Roth et al., 2009;
Takegahara and Kumanogoh, 2010; Staton, 2011; Sakurai et al.,
2012; Takamatsu and Kumanogoh, 2012). Vital to our under-
standing of these functions of the Sema3s is our understanding
of their receptors. However, our knowledge of the composition
of the holoreceptors for the Sema3s is far from complete (Raper,
2000), and we lack a recent detailed and comprehensive review of
what is known.
In this review we present the current state of knowledge on
Sema3 receptors, deduced from bioassays and biochemical and
in vivo analyses, with particular emphasis on neural cells. It is our
hope that this review helps to shed light on those areas most in
need of further research.
GENERAL STRUCTURE OF A CLASS 3 SEMAPHORIN
RECEPTOR
The receptors for the Sema3s are heterocomplexes of recep-
tor subunits, with significant overlap between different Sema3
holoreceptors (Feiner et al., 1997; Takahashi et al., 1998; Rohm
Sema3s were Neuropilin 1 and 2 (Nrp1, Nrp2), independently
reported by two laboratories in 1997 (Chen et al., 1997; He and
Tessier-Lavigne, 1997; Kolodkin et al., 1997). Both Nrp1 and
Nrp2 were found to be essential for Sema3 signal transduction,
but the specificity of Sema3 signaling could not be attributed
to either Neuropilin alone (Chen et al., 1997; Takahashi et al.,
1998). Indeed, even before the discovery that the Neuropilins were
essential for Sema3 signaling, it was inferred from the structure
of Nrp1 and its expression profile in the developing mouse ner-
vous system that Nrp1 was likely heterophilic (Kawakami et al.,
1996). Also, the cytoplasmic domains of Nrp1 were found to be
not required for Sema3 signaling (Nakamura et al., 1998; Renzi
et al., 1999), indicating that Neuropilins act in concert with other
receptor co-receptors which transduce the extracellular signals to
the intracellular signaling pathways.
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Class A Plexins (PlexinAs) are the main co-receptors for the
Sema3s, and were the first identified (Takahashi et al., 1999;
Tamagnone et al., 1999). These initial studies found that PlexinAs
associate with the Neuropilins and that this association is impor-
tant for signal transduction of the Sema3s. Further studies dis-
covered a number of other co-receptors for the Sema3s: L1cam
(Castellani et al., 2000), Nrcam (Falk et al., 2005), Plxnb1 (Usui
et al., 2003), and Plxnd1 (Gitler et al., 2004; Gu et al., 2005;
Chauvet et al., 2007). A summary of known receptor components
for each of the Sema3s is presented in Table 1.
Reviews of the general structure and signaling of the Sema3
holoreceptors have been published previously (Pasterkamp and
Kolodkin, 2003; Geretti et al., 2008; Pellet-Many et al., 2008;
Zhou et al., 2008; Yoshida, 2012), consequently these concepts
are only briefly revisited here. With the exception of Sema3e,
all Sema3 receptors require a Neuropilin to act as the bind-
ing site for the Sema3 ligand. The binding of the Sema3 lig-
ands to the Neuropilins depends on their N-terminus Sema
sequence, and a 70 amino acid stretch within that sequence
determines specificity (Koppel et al., 1997). The receptors for
the Sema3s are multimeric, with varying numbers of associ-
ated Plexins or cell adhesion molecules (CAMs) providing the
intracellular signaling mechanics. Sema3e differs in that it is
able to bind directly to Plxnd1 in the absence of a Neuropilin
(Gu et al., 2005). The Plexins (Class A, with the exception of
Plxnd1 for Sema3e) and CAMs (L1cam and Nrcam) cis-interact
with Nrp1 and Nrp2 through their transmembrane, and extra-
cellular domains (Tamagnone et al., 1999; Rohm et al., 2000;
Takahashi and Strittmatter, 2001; Castellani et al., 2002; Roth
et al., 2008).
METHODOLOGIES USED TO INVESTIGATE RECEPTOR
COMPOSITIONS
A number of in vitro methods have been used to investigate the
function of the Sema3s: axon repulsion/attraction assays, grown
cone collapse assays, COS cell collapse, co-immunoprecipitation,
Table 1 | Known receptor-ligand interactions.
Sema3a Sema3b Sema3c Sema3e Sema3f Sema3g
Nrp1 + + + +/− +/− −
Nrp2 − + + − + +
Plxna1 +/− ? +/− ? + ?
Plxna2 +/− ? + ? + ?
Plxna3 +/− ? ? ? +/− ?
Plxna4 + ? ? ? +/− ?
Plxnb1 + ? + ? ? ?
Plxnd1 +/− ? + + ? ?
L1cam + − ? − ? ?
Nrcam ? + ? ? + ?
Robo1 ? ? ? ? ? ?
Chl1 +/− ? ? ? ? ?
+ receptor/co-receptor necessary for signal transduction; – receptor/co-receptor
not necessary for signal transduction; +/– receptor/co-receptor necessary for
signal transduction under some circumstances; ? no evidence on requirement
of receptor/co-receptor for signal transduction.
and ligand binding assays. To aid the reader in understanding
how deductions about the makeup of Sema3 receptor complexes
have been made, an overview of the methods used to elucidate the
makeup of the Sema3 receptor complexes is given in Figure 1, and
a brief description of these assays is given below.
Having first been discovered as repulsive axon guidance
molecules, it was natural for investigators to use this function
to dissect the receptor makeup for the Sema3s. Neural tissue
explants [usually embryonic dorsal root glia (DRG)] are grown
in a collagen matrix adjacent to cells (normally HEK-293 or COS
cells) transfected to over-express a specific Sema3. The collagen
matrix allows the formation of a gradient of Sema3s from the
transfected cells toward the DRG explants. The most common
method for quantifying the repulsion or attraction this bioassay
is by measuring the length of neurites exiting the explant in the
quadrants proximal and distal to the Sema3 source. Average neu-
rite lengths are then either compared directly, or represented as a
ratio of proximal/distal neurite lengths (Messersmith et al., 1995;
Kolodkin et al., 1997).
Another bioassay enabling analysis of neuronal response to
Sema3s is a growth cone collapse assay. Explants are grown in vitro
and then exposed to exogenous Sema3 ligand for up to one hour
before fixation and staining. The number of collapsed versus
non-collapsed growth cones is then counted and compared by
statistical means (Kapfhammer et al., 2007). It is important to
note that this method captures only inhibitory effects on growth
cones, and may miss any attractant or growth promoting effects
(Campbell et al., 2001).
Another technology that has proved useful for investigating the
Sema3 receptors is to engineer COS and HEK-293 cells to over
express different combinations of Sema3 receptor components.
When COS cells express a minimum functional Sema3 recep-
tor, they collapse if presented with that Sema3 (Takahashi et al.,
1999), thus elucidating necessary components for each Sema3
receptor. Further, COS and HEK-293 cells that over express com-
binations of receptor components have allowed researchers to
study the interactions of these components with each other by
co-immunoprecipitation. This technique is especially important,
as until recently reliable commercial antibodies against specific
Sema3s and their receptor components were scarce, making co-
immunoprecipitation from animal tissue difficult at best. Ectopic
expression of Sema3 receptor subunits also allows measurement
of binding affinities of the Sema3s to different permutations
of the general Sema3 receptor complex. For example, recom-
binant Sema3 ligands fused to a reporter sequence (for exam-
ple FLAG/Myc/alkaline phosphatase) are exposed to engineered
COS/HEK-293 cells, level of binding then visualized via the
reporter sequence, and binding affinities calculated by Scatchard
analysis (Chen et al., 1997; He and Tessier-Lavigne, 1997).
Recombinant Sema3 ligands conjugated to reporter sequences
have also been used to map binding to different tissues both
in vitro and ex vivo. Analysis of the expression of the different
Sema3 receptor constituents in different tissues has then allowed
deduction of the necessity of individual receptor components in
each Sema3 holoreceptor.
The above methods have been combined with various mod-
els to study the makeup of the Sema3 receptors: genomic
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FIGURE 1 | Methods used to investigate Sema3 receptor components.
(A) Attraction/repulsion assay. The area of wavy lines represents aggregates
of COS/HEK-293 cells over-expressing a Sema3. To the right is neuronal
tissue with outgrowth of neurites. In this assay, the average or total lengths
of neurites in the proximal and distal quadrants of the neuronal tissue (with
respect to the COS/HEK-293 cell aggregates) are compared to quantify the
amount of attraction or repulsion. (B) Neurites in vitro with active growth
cones are exposed to exogenous Sema3 or vehicle. Changes in the
percentage of active to collapsed growth cones are used to determine the
biological activity of the Sema3s on different neuronal types. In this example,
neurites are found to collapse in the presence of Sema3a but not Sema3f.
(C) COS/HEK-293 cells are transfected to ectopically express one or more
putative Sema3 receptor components. These cells are then exposed to
exogenous recombinant Sema3 which includes an artificial conjugate, most
often alkaline phosphatase. After incubation at 4◦C the cultures are washed
and stained either by immunocytochemistry, or direct application of a
chromagen that interacts with the artificial conjugate (for example NBT/BCIP
with alkaline phosphatase). The intensity of staining is proportional to the
binding kinetics of the recombinant Sema3 to the putative receptor
components and/or complexes, and the dissociation constant can be derived
by Scatchard analysis. In this way researchers can compare the relative
affinity for the Sema3s to putative receptor components and complexes.
For example, in this diagram, Sema3a, but not Sema3f binds to cells
expressing Nrp1, and Sema3a binds more to cells expressing both Nrp1 and
Plxna1, than Nrp1 alone. (D) COS cells engineered to over-express one or
more putative Sema3 receptor components collapse on exposure to
exogenous Sema3, if those receptor components form a functional receptor
for that Sema3. In the example here, Nrp1 or Plxna1 can transduce a Sema3a
signal when expressed in concert, but not individually. Furthermore, Nrp1 and
Plxna1 cannot transduce a Sema3f signal, either individually or together.
(E) Co-immunoprecipitation experiments allow researchers to investigate
whether two or more receptor components interact either in vivo, or in vitro.
In this example HEK-293 cells are engineered to ectopically express
combinations of either Nrp1 or Nrp2, and L1cam. The recombinant proteins
are conjugated to artificial epitopes which allows for their selective
immunoprecipitation, in this case by the HA tag on the Nrp1/Nrp2. Once
selected for, the proteins are analysed by western blot for any other proteins
of interest that were bound to Nrp1/Nrp2 in the cell. In this example L1cam is
analysed by the immunoblot, and appears associated with only Nrp1, and not
Nrp2. Importantly the controls reveal that the L1cam signal is not detected in
cells expressing L1cam alone, confirming the positive signal in Nrp1/L1cam
cultures as due to Nrp1 and L1cam interaction.
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knock-out/knock-in, gene knock-downs, protein over expression,
functional blocking antibodies, and tissues that are known to
express different combinations of the Sema3 receptor compo-
nents (for example sympathetic neurons versus sensory neurons).
In addition to the above, researchers have also carefully analysed
the in vivo phenotypes of single and double knock-out mutant
animals.
Sema3a
Sema3a was the first Sema3 to be discovered (Kolodkin et al.,
1992; Luo et al., 1993), and has been the most widely studied. As a
result, knowledge of the Sema3a receptor is the most complete of
all the Sema3s. Nonetheless, the make-up of the Sema3a receptor
remains somewhat equivocal.
NEUROPILINS
Nrp1
Nrp1 was identified as a receptor for Sema3a by screening for
Sema3a-AP binding of COS cells transfected with a cDNA expres-
sion library from E14 rat dorsal root ganglia (DRG, sensory
neurons that bind recombinant Sema3a) (He and Tessier-Lavigne,
1997; Kolodkin et al., 1997). The same studies confirmed Nrp1
as a candidate receptor protein for Sema3a by demonstrating that
the proteins co-immunoprecipitate, and that Sema3a-AP binds to
exogenously expressed recombinant Nrp1 in COS cells.
Additional evidence for Nrp1 as a receptor for Sema3a came
from studies using functional blocking antibodies against Nrp1.
Anti-Nrp1 antibodies ablate the axon repulsion and growth cone
collapse effect of recombinant Sema3a on E14 rat DRGs (He and
Tessier-Lavigne, 1997; Kolodkin et al., 1997) and sympathetic
neurons (Chen et al., 1998). Also, anti-Nrp1 antibodies abol-
ish Sema3a mediated axon repulsion of mouse cortical neurons
(Castellani et al., 2000). Similarly,Npr1Sema knock-out (a targeted
deletion in the Sema region of Nrp1, removing Sema3 bind-
ing capability but leaving VEGF binding intact) in mice, causes
Sema3a insensitivity in embryonic DRG neurons (Kitsukawa
et al., 1997; Gu et al., 2003).
Corresponding evidence that Nrp1 is a receptor for Sema3a
comes from over expression studies; Sema3a insensitive chick
E8 retinal neurons become sensitive to Sema3a mediated growth
cone collapse after they are transduced with recombinant Nrp1
(Nakamura et al., 1998). Furthermore, in Xenopus, retinal neu-
rons become responsive to Sema3a induced growth cone collapse
during development, concomitant with expression of Nrp1, and
earlier sensitivity can be conferred using transfection to ectopi-
cally express Nrp1 (Campbell et al., 2001).
Nrp2
Initially it was shown that, unlike Nrp1, Nrp2 is unable to bind
Sema3a in vitro (Chen et al., 1997; Takahashi et al., 1998). Also,
soluble Nrp2-Fc abolishes Sema3c and Sema3f induced axon
repulsion of embryonic rat sympathetic neurons in vitro, but
has no effect on Sema3a induced repulsion in the same model
(Chen et al., 1998). However, more recently Sema3a has been
found to bind to COS cells expressing Nrp2 (albeit 1.3 fold less
than Nrp1 expressing COS cells), and a functional blocking anti-
body against Nrp2 removes the chemorepulsive effect of Sema3a
on at least one human glioma cell line in vitro (Nasarre et al.,
2009). In vivo, Sema3a binding to tissue is abolished in areas such
as the olfactory bulb in Nrp1Sema knockouts, but is still present
in other tissues (Cariboni et al., 2011). Indeed, Sema3a binding
is only completely absent in Nrp1Sema/Nrp2 double knockouts,
and both Neuropilins appear to be partially redundant for one
another in transducing Sema3a signals in mouse vomeronasal
axons (Cariboni et al., 2011). Thus while Nrp1 appears to be an
essential component of a functional Sema3a receptor complex,
Nrp2 may or may not be necessary, depending on the cell type.
CLASS A PLEXINS
COS cells ectopically expressing both Nrp1 and Plxna1 undergo
collapse, or rounding up, in the presence of Sema3a, but no such
reaction occurs if only Nrp1 or Plxna1 is expressed (Takahashi
et al., 1999; Takahashi and Strittmatter, 2001). Moreover, the
presence of Plxna1 increases the affinity of Nrp1 for Sema3a in
vitro, and Nrp1 and Plxna1 cluster in E7 chick DRG growth
cones in response to exogenous Sema3a (Takahashi et al., 1999).
In addition, expression of a dominant negative Plxna1 protein
(lacking the intracellular domain) abolishes growth cone col-
lapse in response to Sema3a in chick E7 DRG neurons (Takahashi
et al., 1999), mouse E12.5 sensory ganglia (Rohm et al., 2000),
and Xenopus laevis spinal neurons (Tamagnone et al., 1999).
Intriguingly, it has been suggested that the presence of Plxna1 in
the Sema3a holoreceptor acts as an adapter for the association
of Plxnb1, increasing the possible signaling cascade complexity
(Usui et al., 2003).
Similarly, embryonic mouse sensory ganglia lose their sen-
sitivity to exogenous Sema3a in vitro when induced to express
ectopic dominant negative Plxna2 protein (Rohm et al., 2000).
Furthermore, COS cells expressing both Plxna2 andNrp1 collapse
in the presence of Sema3a, but not if expressing only one of Plxna2
orNrp1 (Takahashi and Strittmatter, 2001). Finally, co-expression
of both Plxna2 and Nrp1 in HEK-293 cells increases their affin-
ity for Sema3a above those expressing Nrp1 alone (Rohm et al.,
2000).
However, while both Plxna1 and Plxna2 are important for
Sema3a signaling, neither Plxna1 nor Plxna2 appear to be essen-
tial components of the Sema3a holoreceptor. In mouse knockout
models, the facial nerve of Plxna1 and Plxna2 knockouts does
not exhibit the same level of abnormal phenotype as the Sema3a
knockout (Schwarz et al., 2008). This indicates some degree of
redundancy in the make-up of the full Sema3a receptor, with dif-
ferent components conveying overlapping signaling capabilities.
Such redundancy is particularly marked with Plxna3 and
Plxna4 (Schwarz et al., 2008). Plxna3 knockouts have reduced
sensitivity to Sema3a mediated axon repulsion and growth cone
collapse in mouse embryonic DRG, hippocampal neurons, and
embryonic sympathetic neurons (Cheng et al., 2001; Bagri et al.,
2003; Yaron et al., 2005). Similarly, Plxna4 knockouts display
a reduced sensitivity of mouse embryonic DRG and sympa-
thetic neurons (Suto et al., 2005; Yaron et al., 2005). However,
Plxna3/Plxna4 double-knockouts completely abolish sensitiv-
ity to Sema3a induced growth cone collapse and axon repul-
sion (Yaron et al., 2005), strongly suggesting that Plxna3 and
Plxna4 are partially redundant for each other within the Sema3a
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holoreceptor. Further evidence for the reciprocal redundancy of
Plxna3 and Plxna4 in the Sema3a receptor is found in the migra-
tion of sympathetic neurons, which is disrupted by double, but
not single, Plxna3 and Plxna4 knockouts (Waimey et al., 2008).
Finally, Plxna3 is required for Sema3a induced neuron cell death,
but the absence of Plxna4 also reduces this effect of Sema3a by
around 50% (Ben-Zvi et al., 2008).
It appears from the above evidence that Plxna3 and Plxna4
are part of the Sema3a holoreceptor, but partially mutually
redundant, probably sharing overlapping signaling mechanisms.
Interestingly, co-expression of Plxna3 and Nrp1 is not sufficient
to confer sensitivity of COS cells to Sema3a mediated cell col-
lapse, (Takahashi and Strittmatter, 2001), again indicating that
whilse Plxna3 is part of the Sema3a holoreceptor, it is not essen-
tial. However it must be noted that all experimental avenues have
as yet not been exhausted, as illustrated by a very recent report
showing that Plxna4 is essential for Sema3a signaling in HUVECs,
an endothelial cell line (Kigel et al., 2011).
One other Plexin that has been studied as a putative compo-
nent of the Sema3a receptor is Plxnd1. Sema3a binding to Nrp1
is enhanced by the presence of Plxnd1, at least in transfected
COS cells in vitro (Gitler et al., 2004), indicating a possible role
for Plxnd1 in Sema3a signaling. However, there have been no
functional studies performed to test this hypothesis.
L1cam
L1cam has been demonstrated to be important for signal trans-
duction within the Sema3a receptor complex (Castellani et al.,
2000, 2002, 2004). Mouse cortical and DRG neurites, normally
repulsed by Sema3a in co-culture assays, are indifferent to Sema3a
when L1cam is genetically knocked out (Castellani et al., 2000;
Bechara et al., 2008). Importantly, COS cells over-expressing
L1cam and Nrp1 collapse in the presence of Sema3a, indicating
that L1cam can transduce the Sema3a signal (Castellani et al.,
2004).
Interestingly, L1cam appears to be important forNrp1, but not
Nrp2, signaling. When co-expressed in COS cells, both Nrp1 and
L1cam, but notNrp2 and L1cam, naturally associate, independent
of the presence of Sema3a (Castellani et al., 2000). Furthermore,
Nrp1 and L1cam from postnatal mouse brain lysates also co-
immunoprecipitate, with the extracellular portion of L1cam suf-
ficient for binding of L1cam to Nrp1 (Castellani et al., 2000).
Nevertheless, the presence of L1cam is not necessary for
the binding of Sema3a to Nrp1, at least in COS cells in vitro
(Castellani et al., 2000). Furthermore, L1cam is not a necessary
component of the Sema3a receptor, as shown under a number
of circumstances. For example, neuronal apoptosis induced by
Sema3a signaling is not affected by the lack of functional L1cam
(Ben-Zvi et al., 2008). Therefore, as with other co-receptors
for Sema3a, L1cam can transduce Sema3a signals but it is not
essential for all Sema3a signaling under all circumstances.
Finally, the effect of the presence of L1cam in the Sema3a
receptor is more nuanced than simply enabling/disabling Sema3a
signaling. L1cam dependent, Sema3a induced neurite repulsion
in vitro is converted into attraction by the addition of L1-Fc, the
extracellular domain of L1cam fused with and Fc immunoglob-
ulin fragment (Castellani et al., 2000), and similar extracellular
soluble L1cam is present in vivo (Maretzky et al., 2005). Thus the
presence of L1cam in the Sema3a receptor complex enables the
cell to respond to the levels of both Sema3a and soluble L1cam.
Chl1
Chl1 (Close homologue of L1) associates with Nrp1 both in vivo
and in vitro, and is necessary for Sema3a induced embry-
onic mouse thalamic and cortical neuron growth cone collapse
(Wright et al., 2007; Schlatter et al., 2008). Interestingly, Chl1
mediated Sema3a signaling is dependent on a juxtamembrane
region of Chl1’s cytoplasmic domain, conserved with L1cam
(Wright et al., 2007). However, the number of studies of Chl1 and
Sema3 signaling are limited, and it is not possible to say whether
Chl1 is an essential receptor component generally or only has a
role in specific cell types.
Robo1
To date there has been one report of Robo1 acting as a co-
receptor for Sema3a (Hernández-Miranda et al., 2011). Co-
immunoprecipitation from embryonic mouse forebrain, and
COS cells over-expressing Nrp1, Nrp2, Plxna1, Plxna4, and Robo1
demonstrated that Robo1 can form a complex with Nrp1, but not
Nrp2, Plxna1, or Plxna4 individually. Further evidence was gath-
ered from a covasphere aggregation assay [immunofluorescent
beads (green or red) coated with relevant Fc proteins; heterophilic
aggregates are yellow, homophilic aggregates are green or red],
where Robo1 interacted with Nrp1, but not Nrp2, Plxna1, or
Plxna4. Also, co-immunoprecipitation of Robo1 with Plxna1, and
Plxna4 from embryonic mouse forebrain lysates indicates that it
can bind to Nrp1 in complex with Plxna1 and Plxna4, a complex
that would constitute a functional Sema3a receptor.
This binding of Robo1 to Nrp1 depends, at least in part, on
the first two Ig domains in Robo1, but not the final three. Also,
by using the same covasphere assay it was found that Robo1
cannot bind Sema3a directly, and Sema3a did not bind to COS
cells ectopically expressing Robo1 alone. It is still unclear, how-
ever, whether Robo1 is part of the Sema3a receptor complex. The
chemorepulsive effects of Sema3a and Sema3f on both mouse
embryonic medial ganglionic eminence GN11 cells were reduced
in Robo1 knockout animals, despite the fact that Robo1 only inter-
acts with Nrp1 and not Nrp2, an essential component of the
Sema3f receptor complex. Indeed it appears that the effect of
Robo1 knockout on Sema3a and Sema3f induced chemorepulsion
is the concomitant down-regulation of Nrp1 and Plxna1 expres-
sion. The mechanism by which Robo1 expression modulatesNrp1
and Plxna1 expression is as yet unknown, however, this genetic
interaction is in itself an intriguing new facet of Sema3 receptor
biology.
Sema3b
Unlike Sema3a, Sema3b binds to both Nrp1 and Nrp2 following
ectopic expression in COS cells in vitro (Takahashi et al., 1998).
Soluble Nrp2-Fc binds to mouse sub-ventricular zone (SVZ)
regions expressing Sema3b, and this binding is markedly reduced
or extinguished in Sema3b knockouts (Falk et al., 2005). Both
anti-Nrp2 antibodies and exogenous soluble Nrp2 (Nrp2-Fc)
abolished Sema3b induced attraction of mouse neonatal cortical
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neurons (Falk et al., 2005). Also, chick embryonic DRG neu-
rons that are normally insensitive to Sema3b induced growth
cone collapse in vitro become sensitized upon transduction with
recombinant Nrp2 (Takahashi et al., 1998). While Sema3b can
bind both Nrp1 and Nrp2, and it is known that Nrp2 is essential
for Sema3b signal transduction, it remains unclear whether the
presence of Nrp1 is necessary even though Sema3b can bind to
Nrp1 in the absence of Nrp2, as demonstrated by its competitive
antagonism to Sema3a in embryonic chick RGCs (which express
Nrp1 but not Nrp2) (Takahashi et al., 1998).
Similarly, there is no evidence yet for the Plexins as con-
stituents of the Sema3b receptor complex. However several
IgCAMs have been investigated, with Nrcam but not Tag-1,
Contactin, or L1cam able to bind Nrp2 when co-expressed in
HEK-293 in vitro (Castellani et al., 2000; Falk et al., 2005). L1cam
is not required for Sema3b signal transduction in neonatal mouse
cortical neurons (Castellani et al., 2000), and Nrcam, either in its
soluble or membrane bound form, cannot bind Sema3b directly
(Falk et al., 2005) However,Nrcam is essential for neonatal mouse
cortical neuron sensitivity to Sema3b (Falk et al., 2005). Further,
functional blocking antibody against Nrcam abolishes Sema3b
mediated growth cone collapse and axon attraction of neonatal
mouse cortical neurons (Falk et al., 2005). Intriguingly, Nrcam
can mediate neuronal sensitivity to Sema3b by reducing Calpain1
proteolytic activity on Plxna1 (Nawabi et al., 2010).
Lastly, there is no direct evidence for Robo1 as a con-
stituent of the Sema3b holoreceptor. However, Robo1 does co-
immunoprecipitate with Nrp1, Nrp2, Plxna1, and Plxna4, despite
only being able to bind Nrp1 directly (Hernández-Miranda et al.,
2011), This indicates that Robo1 is at least capable of forming a
complex with a Nrp1/Nrp2 heterodimers, leaving open the pos-
sibility that Sema3b signals through a multimeric receptor with a
composition that is as complex as the Sema3a receptor.
Sema3c
Similar to Sema3b, Sema3c binds to both Nrp1 and Nrp2 ectopi-
cally expressed in COS and HEK-293 cells in vitro (Chen et al.,
1997; Feiner et al., 1997; Takahashi et al., 1998; Rohm et al.,
2000). Expression of a dominant negative Nrp1 receptor (lacking
extracellular domain) in embryonic chick sympathetic neurons
abrogates Sema3c induced growth cone collapse (Renzi et al.,
1999), and Sema3c acts as a competitive antagonist to Sema3a
in chick embryonic retinal ganglion cells that express Nrp1 but
not Npr2 (Takahashi et al., 1998). Also, COS cells ectopically
expressing Plxna1/Plxna2/Plxna3 and either Nrp1 orNrp2 do not
collapse in the presence of exogenous Sema3c, but do collapse in
the presence of either Sema3a or Sema3f (Takahashi et al., 1999;
Takahashi and Strittmatter, 2001). Furthermore when embry-
onic chick DRG, which normally express Nrp1 but not Nrp2, are
transduced to ectopically express Nrp2 they become responsive
to Sema3c induced growth cone collapse (Takahashi et al., 1998).
Thus the holoreceptor for Sema3c requires both Nrp1 and Nrp2
to be present.
There is little evidence that Plxna1 is essential for Sema3c
signal transduction. Unlike for Sema3a and Sema3f, Plxna1 co-
expression in COS cells with either Nrp1 or Nrp2 does not
increase the binding affinity for Sema3c, and there is no collapse
response (Takahashi et al., 1999; Rohm et al., 2000; Gitler et al.,
2004). Conversely, there is some evidence that Plxna2 is impor-
tant for Sema3c signaling; Plxna2 positive mouse cardiac neural
crest cells show aberrant migration in Sema3c knockouts (Brown
et al., 2001). However, the same line of evidence suggests that
Nrp2 is not important for the migration of mouse cardiac neu-
ral crest cells (Chen et al., 1997), even though it has been shown
that Nrp2 is essential for Sema3c signaling, at least in neurons
(see above). Furthermore, Plxna2 co-expression with Nrp2 in
COS cells does not increase the affinity of Sema3c binding above
expression of Nrp2 alone (Rohm et al., 2000). It must be noted
that binding analyses conducted so far have studied Plxna1 and
Plxna2 in the presence of either Nrp1 or Nrp2, but not Nrp1 and
Nrp2 together. It is possible that Plxna1 and Plxna2 can change
the binding affinity of Sema3c to its receptor when bothNrp1 and
Nrp2 are present, especially as both are essential for functional
transduction of the Sema3c signal.
Unlike Plxna1 and Plxna2, the interaction of Plxnd1 with
either Nrp1 or Nrp2 does increase their binding affinity Sema3c
(Gitler et al., 2004). However, Plxnd1 knockouts show defects in
the cardiac outflow tract that are remarkably similar to those seen
in Sema3c knockouts (Gitler et al., 2004). While, unlike Sema3e,
Sema3c cannot bind directly to Plxnd1 in vitro (Gu et al., 2005),
both Nrp1 and Nrp2 bind to Plxnd1 as demonstrated by co-
immunoprecipitation (Gitler et al., 2004; Chauvet et al., 2007),
and Plxnd1 may form a part of the Sema3c receptor complex via
this interaction.
As with Sema3b, there is no direct evidence that Robo1 is a
constituent of the Sema3b holoreceptor. However, because Robo1
co-immunoprecipitates with receptor components of the Sema3c
receptor it is possible that Robo1 forms a complex within the
Sema3c holoreceptor (Hernández-Miranda et al., 2011).
Sema3d
Little is known about the receptor for Sema3d. What is known
is that Sema3d can bind to Nrp1 ectopically expressed by COS
cells in vitro (Feiner et al., 1997). There is also some evidence
in vivo that Nrp1 is important for Sema3d signaling in zebrafish,
as Nrp1 knockdowns phenocopy Sema3d knockdowns; losing
axon repulsion of axons from the nucleus of the medial longitu-
dinal fasciculus (Wolman et al., 2004). The same study suggested
that Nrp2 may be a constituent of the Sema3d receptor, as knock-
down of Sema3d or Nrp2 showed a similar phenotype. It was also
initially thought that Sema3d influenced fasciculation of axons in
the nucleus of the medial longitudinal fasciculus through a recep-
tor incorporatingNrp1, but it was later revealed that fasciculation
is influenced by Sema3d modulating expression of L1cam on the
axons (Wolman et al., 2007).
Sema3e
Unlike all other Sema3s, Sema3e can bind to a Plexin, Plxnd1,
directly and independently of the Neuropilins. Also, exogenous
Sema3e collapses COS cells expressing ectopic Plxnd1 (Gu et al.,
2005). Further in vitro evidence implicating Plxnd1 as an essen-
tial component of the Sema3e receptor is that Sema3e mediated
axon growth inhibition and growth cone collapse of embryonic
mouse cortical neurons is abolished in both Plxnd1 knockout and
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knockdown models (Chauvet et al., 2007). Furthermore, Plxnd1
expression is essential for Sema3e mediated modelling of chick
vasculature both in vivo, and in vitro (Gu et al., 2005), and
observed metastatic activity of Sema3e is dependent on activation
of Plxnd1 associated ErbB2/Neu oncogenic kinase (Casazza et al.,
2010).
While Sema3e is able to exert a biological effect independent
of Neuropilins, there is evidence that Nrp1 is able to modulate
Sema3e signaling, because Sema3e induced growth cone collapse
of embryonic mouse DRG is inhibited by the addition of anti-
Nrp1 antibody (Miyazaki et al., 1999). Similarly, Sema3e induced
neurite growth from subicular neurons in vitro is abolished by
treatment with anti-Nrp1 functional blocking antibody, and by
knockdown of Nrp1 (Chauvet et al., 2007). Interestingly, after
Nrp1 gain of function, cortical neurons convert their response
to Sema3e in vitro, from neurite inhibition to neurite extension,
and this sensitivity is still able to be abolished by knockdown of
Plxnd1 (Chauvet et al., 2007). The presence ofNrp1 in the Sema3e
receptor complex may “gate” cellular response between attractive
and repulsive, through interaction of the extracellular domains of
Plxnd1 and Nrp2 (Chauvet et al., 2007).
Sema3f
Sema3f is one of the most studied of the Sema3s and its receptor
complex is one of the best understood.
NEUROPILINS
Sema3f binds to COS cells ectopically expressing Nrp1, with a
similar affinity as Sema3a binding to Nrp1 (Chen et al., 1997). In
vitro, exogenous Sema3f inhibits cell attachment and spreading
in the breast cancer cell line MCF7, a line that expresses Nrp1 but
not Nrp2; this inhibition is blocked by the addition of anti-Nrp1
functional blocking antibody (Nasarre et al., 2003). However,
exogenous Sema3f is unable to cause contraction of COS cells in
vitro expressing Nrp1 or Nrp1 and one of Plxna1/Plxna2/Plxna3
(Takahashi and Strittmatter, 2001), raising the possibility that
Sema3f signaling through Nrp1 requires the presence of an as yet
unidentified co-receptor.
Intriguingly C100, a breast cancer cell line that expresses both
Nrp1 and Nrp2, responds to exogenous Sema3f with inhibition
of cell spreading, and this response is insensitive to the addi-
tion of anti-Nrp1 functional blocking antibody (Nasarre et al.,
2003). Similarly in embryonic rat DRG, which also express both
Nrp1 and Nrp2, Sema3f induced axon repulsion is unaffected by
addition of anti-Nrp1 functional blocking antibody, even though
the same antibody abolishes the repulsive effects of Sema3c and
Sema3a (Chen et al., 1998). Perhaps, at least in some cell types,
when both Nrp1 and Nrp2 are present, the Sema3f receptor is
preferentially composed of Nrp2 over Nrp1. Indeed, the affinity
for Sema3f forNrp2 is around 10 fold greater than forNrp1 (Chen
et al., 1997).
It follows then that Nrp1 may not be an essential component
of the Sema3f receptor complex, as long as Nrp2 is also present.
This hypothesis is supported by the observation that embryonic
chick sympathetic neurons, which normally express both Nrp1
andNrp2, undergo growth cone collapse in the presence of exoge-
nous Sema3f, and over expression of a dominant-negative Nrp1
receptor in these neurons does not remove their Sema3f mediated
growth cone collapse, despite the same model abrogating Sema3a
mediated growth cone collapse (Renzi et al., 1999). The obvious
inference is that Nrp1 is an essential component of the Sema3a
but not the Sema3f holoreceptor.
Sema3f binds to COS cells that ectopically express Nrp2 (Chen
et al., 1997), and exogenous Sema3f induces collapse of COS cells
when they express both Nrp2 and Plxna1 (Takahashi et al., 1999).
Dopaminergic axons grown in vitro from the ventral tegmental
area ofmice are either repelled by, or attracted to, Sema3f depend-
ing on age, an effect which is dependent on Nrp2 (Kolk et al.,
2009). Anti-Nrp2 functional blocking antibody also abolishes
Sema3f induced growth cone collapse of embryonic rat sympa-
thetic neurons, and axon repulsion in neonatal mouse cortical
neurons (Chen et al., 1997; Falk et al., 2005).
Knockout models reinforce the importance of Nrp2 in Sema3f
signaling. Embryonic mouse neural crest cells avoid focal Sema3f
in vitro, but this effect is mollified in neural crest cells from Nrp2
knockout mice (Gammill et al., 2006). In vivo, Sema3f knock-
out models show aberrant growth in multiple Nrp2 expressing
tracts in the mouse brain (Sahay et al., 2003). Similarly, Nrp2
and Sema3f knockouts demonstrate that migration of neural crest
cells during mouse development is dependent on Sema3f sig-
naling through Nrp2 (Gammill et al., 2006). Knockout models
also demonstrate that Sema3f is important for the development
of dopaminergic neurons in the mouse meso-diencephalon, and
that this development is dependent onNrp2 signaling (Kolk et al.,
2009). In the olfactory bulb, Sema3f signaling in olfactory sen-
sory neurons is dependent on their expression of Nrp2 (Takeuchi
et al., 2010), and Sema3f and Nrp2 knockouts phenocopy each
other (Cloutier et al., 2002, 2004).
CLASS A PLEXINS
There is also evidence supporting the role of Plxna1 in the
Sema3f receptor; COS cells expressing bothNrp2 and Plxna1 bind
Sema3f with greater affinity than those expressing Nrp2 alone
(Plxna1 alone is unable to bind Sema3f ) (Takahashi et al., 1999).
Furthermore Nrp2 alone is insufficient to signal COS cell col-
lapse in response to Sema3f, but Nrp2 and Plxna1 expression
combined is able to transduce this signal (Takahashi et al., 1999;
Takahashi and Strittmatter, 2001). Similarly, COS cells transfected
with both Nrp2 and Plxna2, but not Nrp2 alone, collapse in
the presence of exogenous Sema3f (Takahashi and Strittmatter,
2001). Consequently, at least in vitro, Plxna1 and Plxna2 are parts
of a functioning Sema3f receptor complex.
Plxna3 also appears to be a part of the Sema3f holoreceptor.
When Plxna3 is knocked out, mouse sympathetic and hippocam-
pal neurons lose sensitivity to the repulsive effect of Sema3f
in vitro (Cheng et al., 2001; Yaron et al., 2005; Waimey et al.,
2008). Knockouts of Plxna3 and Sema3f are reported to phe-
nocopy the defects of each other in the axon guidance of facial
branchiomotor neurons (Schwarz et al., 2008), and in the olfac-
tory bulb mosaic knockouts of Plxna3 disrupt Nrp2 and Sema3f
dependent olfactory sensory neuron innervation (Takeuchi et al.,
2010). In culture, CA1 pyramidal neurons respond to exoge-
nous Sema3f with axon branch retraction, but this effect
is absent in the same neurons from Plxna3 knockout mice
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(Bagri et al., 2003). However, Nrp2 and Plxna3 co-expression
in COS cells is insufficient to generate a Sema3f mediated cell
contraction response (Takahashi and Strittmatter, 2001), indicat-
ing that Plxna3 requires other co-receptors to form a functional
Sema3f receptor.
Similar to the Sema3a receptor, there is evidence that both
Plxna3 and Plxna4 are partially redundant constituents in the
Sema3f holoreceptor. Embryonic mouse sympathetic neurons
lose their migratory responsiveness to a gradient of Sema3f in
vitro when both Plxna3 and Plxna4 are knocked out, but not if
only one or the other is absent (Waimey et al., 2008). However,
it appears that Plxna3 and Plxna4 do not coincide within the
same Sema3f receptor complex, because co-immunoprecipitation
studies demonstrate that they do not associate with one another,
and this is unaffected by the presence of either Nrp1 or Nrp2
(Waimey et al., 2008). Thus Plxna3 and Plxna4 appear redundant
for each other in Sema3f signaling, but as separate receptor com-
plexes, and the preferential receptor complex is one that contains
Plxna3 (Yaron et al., 2005; Schwarz et al., 2008). Indeed, some
neurons may not form the Plxna4 constituting Sema3f recep-
tor. For example mouse sympathetic neurons express both Plxna3
and Plxna4, however their Sema3f mediated growth cone collapse
response is only abrogated by Plxna3, but not Plxna4, knockout
(Cheng et al., 2001; Suto et al., 2005; Yaron et al., 2005).
Nrcam
Finally, there is also evidence that Nrcam mediates Sema3f sig-
naling. Mouse piriform cortical neuron growth cones collapse
in the presence of Sema3f in vitro but this effect is abolished in
the presence of soluble Nrcam-Fc or anti-Nrcam antibody (Falk
et al., 2005). Nrcam associates with Nrp2, and when Nrcam is
knocked out, thalamic neurons lose their sensitivity to Sema3f
(Demyanenko et al., 2011).
Sema3g
Sema3g is the most recently discovered member of the Sema3s
(Stevens and Halloran, 2005; Taniguchi et al., 2005). While there
is growing evidence for the importance of Sema3g in cancer biol-
ogy, cell migration, and axon guidance (Taniguchi et al., 2005;
Bron et al., 2007; Karayan-Tapon et al., 2008; Kigel et al., 2008;
Neufeld and Kessler, 2008), relatively little is known about its
signaling mechanisms.
Taniguchi et al. (2005) reported that, Sema3g binds to COS
cells expressing Nrp2, but not those expressing Nrp1. In the
same study the researchers found that exogenous Sema3g repelled
sympathetic axons which express Nrp2, but had no attrac-
tive/repulsive effect on dorsal root ganglion axons that don’t
express Nrp2. It can be inferred from these initial studies that
Sema3g acts through Nrp2, but not Nrp1.
DISCUSSION
Our current understanding of the receptors for the Sema3s has
come a long way since the first discovery of Nrp1 and Nrp2.
However, there is still a great deal that remains unclear. It is
evident from the data reviewed above that there is not a single
holoreceptor for each Sema3, and the make-up of a particular
receptor complex depends on cell type, and perhaps also on the
phenotypic status of the cell.
The methods used in the studies detailed in this review remain
useful for further research into the specific receptor subunits that
make up the receptor complexes for each Sema3. However, it
is also important to understand the physical basis of the inter-
actions between the Sema3 ligands, receptors, and co-receptors.
This could contribute to our understanding of why different com-
binations of receptor components are necessary for binding and
signaling of each Sema3. An example of how our knowledge of
the physical interaction of different receptor subunits has led to a
better understanding of how a Sema3 receptor complex functions
is available from studies of the Sema3a/Nrp1/Plxna1 complex.
Takahashi and Strittmatter (2001) put forward a model where
Plxna1 is constitutively inhibited by its Sema domain, and bind-
ing of both Nrp1 and Sema3a together causes a conformational
change, removing the inhibition, and allowing downstream sig-
naling. Also, within the Sema domain of the Sema3s, there
is a 70 amino acid stretch that is responsible for the speci-
ficity in the Sema3s (Koppel et al., 1997). From this, and
Takahashi and Strittmatter’s model, it is probable that the speci-
ficity within that region involves both the ability of each Sema3
to bind specific Neuropilins, and co-receptors such as Plxna1
(Antipenko et al., 2003; Love et al., 2003; Liu et al., 2010).
Interestingly, there is a conserved residue (K108) among all verte-
brate Semaphorins that abuts the aforementioned 70 amino acid
region, and when mutated in Sema3a and Sema3f, abrogates sig-
naling without affecting binding to Nrp1 and Nrp2, respectively,
(Merte et al., 2010). The samemutation in Sema3e does not affect
that molecule’s binding or signaling through Plxnd1, indicating
that if this mutation is having an effect on Semaphorin-Plexin
binding, it is only apparent in Semaphorin-Neuropilin-Plexin
complexes. Indeed, the K108N Sema3a mutation did not affect
binding to Nrp1, but did reduce binding to embryonic mouse
DRG growth cones, indicating that even though the residue
is strongly conserved, its effect is only observed in proximity
to a Neuropilin. The above evidence supports Takahashi and
Strittmatter’s hypothesis, and also indicates that specific regions
of the Sema3 ligands affect recruitment and/or activation of
their co-receptors. Indeed, it appears that that Sema3 binding to
Neuropilins, and Sema3 interaction with Plexins are on quite sep-
arate regions of the Sema3 protein, and targeting of these regions
may allow specific interference with Sema3 signaling.
There are also several other issues relating to Sema3 receptors
that are outside the purpose of this review, but merit comment.
Firstly several of the receptor components of the Sema3 receptor
also act as receptors for other classes of Semaphorins (Toyofuku
et al., 2004; Suto et al., 2005; Yoshida et al., 2006; Suto et al., 2007;
Matsuoka et al., 2011a,b; Taniguchi et al., 2011), and even other
families of proteins such as the vascular endothelial growth factors
(VEGFs) (Soker et al., 1998; Neufeld et al., 2002; Guttmann-Raviv
et al., 2007; Geretti et al., 2008; Zachary et al., 2009), hepato-
cyte growth factor (HGF) (Sulpice et al., 2008; Zachary et al.,
2009), and transforming growth factor β1 (TGFβ1) (Glinka and
Prud’homme, 2008). Secondly, it remains to be determined how
endogenous soluble forms of the Neuropilins and L1cam inter-
act with Sema3 signaling (Gagnon et al., 2000; Rossignol et al.,
2000; Castellani et al., 2002; Lu et al., 2009). Thirdly, the Sema3s
interact with chondroitin sulphate proteoglycans (CSPGs) in
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the extracellular matrix (ECM), and this interaction appears to
potentiate its repulsive activity (DeWit et al., 2005; Zimmer et al.,
2010). Lastly, it is unclear how a particular cell or tissue regulates
its expression of the different components of the Sema3 receptor
complex.
If components of the Sema3 receptor, especially the binding
subunits the Neuropilins, act as receptors for other molecules,
does that mean the Sema3s can act as antagonists against those
other molecules or vice versa? It is known that Sema3 signaling
involves endocytosis of the receptor complex (Castellani et al.,
2004; Tojima et al., 2010), as does VEGF signaling through Nrp1,
albeit by a different mechanism (Narazaki and Tosato, 2006;
Salikhova et al., 2008). Thus it is possible that by sequester-
ing essential receptor subunits, both VEGFs and Sema3s can
act as antagonists (Narazaki and Tosato, 2006; Narazaki et al.,
2008). Indeed, antagonism between Sema3s and VEGFs has been
observed (Nasarre et al., 2003; Geretti et al., 2008). Furthermore,
competitive inhibition of Sema3s on VEGF binding of Nrp2 has
been reported (Nasarre et al., 2005; Geretti et al., 2007), whereas
it appears that Sema3s and VEGFs do not directly compete for
binding toNrp1 (Appleton et al., 2007). In other words, we should
view the Sema3s not only as ligands for their receptors, but also
as possible antagonists of molecules for which they share receptor
components (Takahashi et al., 1998; Parker et al., 2010).
Soluble truncated Neuropilins and L1cam have been identified,
and observed in vivo (Mechtersheimer et al., 2001; Lu et al., 2009).
Soluble Neuropilins can bind VEGF165 (Gagnon et al., 2000), so
it is possible then that they are also able to bind and sequester
Sema3s from functional receptors. These soluble Neuropilins do
not form part of the Sema3s’s holoreceptors, but they are recep-
tors for the Sema3s. Future studies into the effect of the Sema3s
should be mindful of the presence of these soluble Neuropilins,
and their buffering effect taken into account when considering
ligand/receptor binding. Similar note should be made of L1cam
expression, as its soluble form is known to modulate at least
Sema3a signaling (Castellani et al., 2000, 2002, 2004). Another
intriguing finding is that soluble amyloid precursor protein can
bind Sema3a (Magdesian et al., 2011), and may act similar to
soluble Neuropilins as an inhibitor to Sema3 signaling.
Based on the interaction of Sema3a with CSPGs (De Wit et al.,
2005; Zimmer et al., 2010), Zimmer et al. (2010) speculate that
amongst other possible mechanisms, CSPGs may interact directly
with CAMs in the Sema3a receptor complex. CSPGs in the ECM
could also act to stabilize Sema3a for presentation to Sema3a sen-
sitive cells (De Wit et al., 2005). Interestingly, the presence of
heparin and heparan sulphates, but not chondroitin sulphates,
enhances binding and activity of Sema3a to Nrp1 expressing cells
(De Wit et al., 2005), which may be related to the heparin bind-
ing site on Nrp1 (Vander Kooi et al., 2007). Also, via an as yet
unexplained mechanism, Sema3c release from proteoglycans in
the ECM in vitro increases its cell migration effect on MCF7
cells, despite no change in observed binding of Sema3c to the cell
surface (Esselens et al., 2010). These studies show that in some
respects, proteoglycans in the ECM can act as “helper” receptors
for Sema3s, and may play an important role in Sema3 signaling
in vivo.
Finally, factors that influence the regulation of expression of
the Sema3 receptor components are still far from understood. It
is known, for example, that there are changes in expression of
the Neuropilins and PlexinAs during development, after injury,
and in response to at least some growth factors (de Winter et al.,
2002, 2004; Banerjee et al., 2006). Further factors that regulate
expression of both Neuropilins are summarised by Bielenberg
et al. (2006). VEGF regulates the expression of Plxnd1 in the
endothelial cells in the developingmouse retina (Kim et al., 2011).
In Xenopus laevis, fibroblast growth factor regulates expression
of Sema3a (Atkinson-Leadbeater et al., 2010). It is also known
that Sema3d can modulate expression of L1cam, (Wolman et al.,
2004), and that Robo1 similarly affects expression of Nrp1 and
Plxna1 (Hernández-Miranda et al., 2011). Interestingly, Nrcam
sensitises commissural axons to Sema3b by inhibiting the pro-
teolytic degradation of another receptor component, Plxna1
(Nawabi et al., 2010). Furthermore, Sema3a can induce pro-
tein synthesis at the growth cone via upregulation of translation
(Campbell and Holt, 2001), and this could modulate expres-
sion of a wide range of proteins, including receptors. A deeper
understanding of how the expression of Sema3 receptors is reg-
ulated will provide insight into the molecular mechanisms that
cause aberrant expression or receptor components in pathological
situations.
This review brings together the growing number of inves-
tigations into what receptor subunits are important for each
Sema3 ligand. It is apparent that there is still much to learn
about the Sema3 receptors, and that it is important we gain a
fuller understanding of the Sema3 receptor complexes. When
combined with greater knowledge of the signaling cascades
involved with each receptor subunit, there is the tantalising
possibility of designing therapies for the increasing number of
pathological situations in which Sema3s and their receptors are
implicated.
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